The influence of taurine pretreatment on aluminum chloride induced nephrotoxicity in Swiss albino mice

Histology and Histopathology

Volumn 29, Issue 1, 2014, Pages 45-55

  Al Kahtani, Mohammed A ^a   Abdel Moneim, Ashraf M ^a,b   El Sayed, Wael M ^a,c  

^a KING FAISAL UNIVERSITY   (Saudi Arabia)

^b Alexandria University Faculty Of Science   (Egypt)

^c AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

AlCl3; Histopathology; Kidney function; Oxidant stress; Taurine; Ultrastructure

Indexed keywords

ALUMINUM CHLORIDE; ALUMINUM DERIVATIVE; ANTIOXIDANT; CHLORIDE; TAURINE;

ACUTE KIDNEY FAILURE; ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; KIDNEY; KIDNEY FUNCTION TEST; MALE; MOUSE; PATHOLOGY; TRANSMISSION ELECTRON MICROSCOPY;

ACUTE KIDNEY INJURY; ALUMINUM COMPOUNDS; ANIMALS; ANTIOXIDANTS; CHLORIDES; KIDNEY; KIDNEY FUNCTION TESTS; MALE; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; TAURINE;

EID: 84890964292     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (90)

1. Abdel-Moneim A.M. (2009). Mercuric chloride induced ultrastructural changes in hepatic and renal tissues of rats and the protective effects of vitamin C and E. Biochem. Cell. Arch. 9, 113-122.
2. Abdel-Moneim A.M. and Said K.M. (2007). Acute effect of cadmium treatment on the kidney of rats: Biochemical and ultrastructural studies. Pak. J. Biol. Sci. 10, 3497-3506.
3. Aebi H. (1984). Catalase in vitro. Methods Enzymol. 105, 21-126.
4. Alfrey A.C. (1980). Metabolism and toxicity of aluminium in renal failure. Am. J. Clin. Nutr. 33, 1509-1516.
5. Antignac C., Gubler M.C., Leverger G., Broyer M. and Habib R. (1989). Delayed renal failure with extensive mesangiolysis following bone marrow transplantation. Kidney Int. 35, 1336-1344.
6. Baek Y.Y., Cho D.H., Choe J., Lee H., Jeoung D., Ha K.S., Won M.H., Kwon Y.G. and Kim Y.M. (2012). Extracellular taurine induces angiogenesis by activating ERK-, Akt-, and FAK-dependent signal pathways. Eur. J. Pharmacol. 674, 188-99.
7. Baydar T., Sahin G., Aydin A., Lsimer A. and Atakan A. (1998). The aluminum content is some patch test allergens. Biol. Trace Elem. Res. 64, 37-42.
8. Bertholf R., Herman M., Savory J., Carpenter R., Sturgill C.B., Katsetos C.D., Vandenberg S.R. and Wills M. (1998). A long term intravenous model of aluminium maltol toxicity in rabbits: tissue distribution, hepatic, renal and neuronal cytoskeletal changes associated with systemic exposure. Toxicol. Appl. Pharmacol. 98, 58-74.
9. Beutler E., Duron O. and Kelly B.M. (1963). Improved method for the determination of blood glutathione. J. Lab. Clin. Med. 61, 882-888.
10. Cacini W. and Yokel R.A. (1988). Accumulation of aluminium by rabbit renal cortex. Res. Commun. Chem. Pathol. Pharmacol. 59, 93-105.
11. Casey R.G., Gang C., Joyce M. and Bouchier-Hayes D.J. (2006). Taurine attenuates acute hyperglycaemia-induced endothelial cell apoptosis, leucocyte-endothelial cell interactions and cardiac dysfunction. J. Vasc. Res. 44, 31-39.
12. Cherroret G., Capolaghi B., Hutin M.F., Burnel D., Desor D. and Lehr P.R. (1995). Effects of postnatal aluminum exposure on biological parameters in the rat plasma. Toxicol. Lett. 78, 119-125.
13. Csala M., Banhegyi G. and Benedetti A. (2006). Endoplasmic reticulum: a metabolic compartment. FEBS Lett. 580, 2160-2165.
14. Das J., Ghosh J., Manna P. and Sil P.C. (2010). Taurine protects acetaminophen-induced oxidative damage in mice kidney through APAP urinary excretion and CYP2E1 inactivation. Toxicology 269, 24-34.
15. Dawson E.B., Evans D.R., Harris W.A. and Powell L.C. (2000). Seminal plasma trace metal levels in industrial workers. Biol. Trace Elem. Res. 74, 97-105.
16. Dogru-Abbasoglu S., Kanbagli O., Balkan J., Cevikbas U., Aykac-Toker G. and Uysal M. (2001). The protective effect of taurine against thioacetamide hepatotoxicity of rats. Hum. Exp. Toxicol. 20, 23-27.
17. Ebina Y., Okada S., Hamazaki S. and Midorikawa O. (1984). Liver, kidney and central nervous system toxicity of aluminium given intraperitoneally to rats: a multiple dose subchronic using aluminium nitriloacetato. Toxicol. Appl. Phamacol. 75, 211-218.
18. Ecelbarger C.A., Macneil G.G. and Greger J.L. (1994). Importance of kidney function and duration of exposure of aluminium accumulation in mature rats. Nutr. Res. 14, 577-586.
19. Eldin A.A., Shaheen A.A., Abd Elgawad H.M. and Shehata N.I. (2008). Protective effect of taurine and quercetin against renal dysfunction associated with the combined use of gentamycin and diclofenac. Indian J. Biochem. Biophys. 45, 332-340.
20. El-Sayed W.M., Al-Kahtani M.A. and Abdel-Moneim A.M. (2011). Prophylactic and Therapeutic effects of taurine against aluminuminduced acute hepatotoxicity in mice. J. Hazard. Mater. 192, 880-886.
21. Erdem A., Gundogan N.U., Usubutun A., Kilinc K., Erdem S.R., Kara A. and Bozkurt A. (2000). The protective effect of taurine against gentamicin-induced acute tubular necrosis in rats. Nephrol. Dial. Transplant. 15, 1175-1182.
22. Eremina V., Sood M., Haigh J., Nagy A., Lajoie G., Ferrara N., Gerber H.P., Kikkawa Y., Miner J.H. and Quaggin S.E. (2003). Glomerularspecific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J. Clin. Invest. 111, 707-716.
23. Eremina V., Cui S., Gerber H., Ferrara N., Haigh J., Nagy A., Ema M., Rossant J., Jothy S., Miner J.H. and Quaggin S.E. (2006). Vascular endothelial growth factor a signaling in the podocyte-endothelial compartment is required for mesangial cell migration and survival. J. Am. Soc. Nephrol. 17, 724-735.
24. Esser S., Wolburg K., Wolburg H., Breier G., Kurzchalia T. and Risau W. (1998). Vascular endothelial growth factor induces endothelial fenestrations in vitro. J. Cell Biol. 140, 947-59.
25. Esterbauer H., Schaur R.J. and Zollner H. (1991). Chemistry and biochemistry of 4-hydroxynonenal, malondialdehyde and related aldehydes. Free Radic. Biol. Med. 11, 81-128.
26. Exley C. (1998). Does antiperspirant use increase the risk of aluminium related disease, including Alzheimer's disease? Mol. Med. Today 4, 107-109.
27. Exley C. (2004). The pro-oxidant activity of aluminum. Free Rad. Biol. Med. 36, 380-387.
28. Fernandez-Lorenzo J.R., Cocho J.A., Rey-Goldar M.L., Couce M. and Fraga J.M.(1999). Aluminum contents of human milk, cow's milk, and infant formulas. J. Pediatr. Gastroenterol. Nutr. 28, 270-275.
29. Flohe L. and Gunzler W.A. (1984). Assays of glutathione pereoxidase. Methods Enzymol. 105, 114-121.
30. Flora S.J., Chouhan S., Kannan G.M., Mittal M. and Swarnkar H. (2008). Combined administration of taurine and monoisoamyl DMSA protects arsenic induced oxidative injury in rats. Oxid. Med. Cell. Longev. 1, 39-45.
31. Forbes W.F., Gentleman J.F. and Maxwell C.J. (1995). Concerning the role of aluminum in causing dementia. Exp. Gerontol. 30, 23-32.
32. Gartner L.P. and Hiatt J.L. (2001). Color textbook of histology. 2nd ed. W.B. Saunders Company, Philadelphia.
33. Gurer H., Ozgunes H., Saygin E. and Ercal N. (2001). Antioxidant effect of taurine against lead-induced oxidative stress. Arch. Environ. Contam. Toxicol. 41, 397-402.
34. Hagar H.H. (2004). The protective effect of taurine against cyclosporine A-induced oxidative stress and hepatotoxicity in rats. Toxicol. Lett. 15, 335-343.
35. Hagar H.H., El Etter E. and Arafa M. (2006). Taurine attenuates hypertension and renal dysfunction induced by cyclosporine A in rats. Clin. Exp. Pharmacol. Physiol. 33, 189-196.
36. Haugen E. and Nath K.A. (1999). The involvement of oxidative stress in the progression of renal injury. Blood Purif. 17, 58-65.
37. Hong C.B., Fredenburg A.M., Dickey K.M., Lovell M.A. and Yokel R.A. (2000). Glomerular lesions in male rabbits treated with aluminium lactate: With special reference to microaneurysm formation. Exp. Toxicol. Pathol. 52, 139-143.
38. Huxtable R.J. (1992). Physiological actions of taurine. Physiol. Rev. 72, 101-163.
39. Hwang D.F., Wang L.C. and Cheng H.M. (1998). Effect of taurine on toxicity of copper in rats. Food Chem. Toxicol. 36, 239-246.
40. Ichikawa I., Kiyama S. and Yoshioka T. (1994). Renal antioxidant enzymes: Their regulation and function. Kidney Int. 45, 1-9.
41. Indo H.P., Davidson M., Yen H.C., Suenaga S., Tomita K., Nishii T., Higuchi M., Koga Y., Ozawa T. and Majima H.J. (2007). Evidence of ROS generation by mitochondria in cells with impaired electron transport chain and mitochondrial DNA damage. Mitochondrion 7, 106-118.
42. Jagadeesan G. and Sankarsami Pillai S. (2007). Hepatoprotective effects of taurine against mercury induced toxicity in rats. J. Environ. Biol. 28, 753-759.
43. Kaplan L.A. (1984). Urea. In: Clinical chemistry; theory, analysis and correlation. Kaplan L.A. and Pesce A.J. (eds). CV Mosby Company. St. Louis. pp 1257-1261.
44. Koitabashi Y., Rosenberg B.F., Shapiro H. and Bernstein J. (1991). Mesangiolysis: An important glomerular lesion in thrombotic microangiopathy. Mod. Pathol. 4, 161-166.
45. Kriz W., Elger M., Hosser H., Hahnel B., Provoost A., Kranzlin B. and Gretz N. (1999). How does podocyte damage result in tubular damage? Kidney Blood Press. Res. 22, 26-36.
46. Kubo A., Iwano M., Kobayashi Y., Kyoda Y., Isumi Y., Maruyama N., Samejima K., Dohi Y., Minamino N. and Yonemasu K. (2002). In vitro effects of Habu snake venom on cultured mesangial cells. Nephron 92, 665-672.
47. Kurozumi T., Tanaka K., Kido M. and Shoyama Y. (1983). Monocrotaline-induced renal lesions. Exp. Mol. Pathol. 39, 377-386.
48. Kutlubay R., Oguz E.O., Guven C., Can B., Sinik Z. and Tuncay O. (2007). Histological and ultrastructural evidence for protective effects on aluminium-induced kidney damage by intraperitoneal administration of α-tocopherol. Int. J. Toxicol. 26, 95-101.
49. Lakshmi Devi S. and Anuradha C.V. (2010). Mitochondrial damage, cytotoxicity and apoptosis in iron-potentiated alcoholic liver fibrosis: amelioration by taurine. Amino Acids 38, 3869-3879.
50. Lione A. (1985). Aluminum toxicity and the aluminum containing medication. Pharmacol. Therap. 29, 255-285.
51. Lowry O.H., Roseborough N.J., Farr A.L. and Randall R.L. (1951). Protein measurement with Folin phenol reagent. J. Biol. Chem. 193, 265-275.
52. Mahieu S. and Calvo M.L. (1998). Effect of chronic poisoning with aluminium on the renal handling of phosphate in the rat. Toxicol. Lett. 94, 47-56.
53. Mahieu S., Gionotti M., Millen N. and Elias M.M. (2003). Effect of chronic accumulation of aluminium on renal function, cortical renal oxidative stress and cortical renal organic anion transport in rats. Arch. Toxicol. 77, 605-612.
54. Manna P., Sinha M. and Sil P.C. (2008). Cadmium induced testicular pathophysiology: prophylactic role of taurine. Reprod. Toxicol. 26, 282-291.
55. Marzella L. and Lee H-K. (1998). Role of lysosomes in cell injury. In: Principles of medical biology. 13th ed. Bittar E.E. and Bittar N. (eds). JAI Press Inc. pp 167-196.
56. Matsuda M. (1983). Experimental glomerular tissue injury induced by immunization with cultured endothelial cell plasma membrane. Acta Pathol. Jpn. 38, 823-839.
57. Messina S.A. and Dawson R. Jr (2000). Attenuation of oxidative damage to DNA by taurine and taurine analogs. Adv. Exp. Med. Biol. 483, 355-367.
58. Morita H., Isobe K., Cai Z., Miyazaki T., Matsumoto Y., Shinzato T., Yoshikai Y., Kimata K. and Maeda K. (1996). Thy-1 antigen mediates apoptosis of rat glomerular cells in vitro and in vivo. Nephron 73, 293-298.
59. Murray R.L. (1984). Creatinine. In: Clinical chemistry; theory, analysis and correlation. Kaplan L.A. and Pesce A.J. (eds). CV Mosby Company. St. Louis. pp 1247-1253.
60. Nehru B. and Anand P. (2005). Oxidative damage following chronic aluminium exposure in adult and pup rat brains. J. Trace Elem. Med. Biol. 19, 203-208.
61. Orihuela D., Meichtry V., Pregi N. and Pizarro M. (2005). Short-term oral exposure to aluminium decreases glutathione intestinal levels and changes enzyme activities involved in its metabolism. J. Inorg. Biochem. 99, 1871-1878.
62. Ozden S, Catalgol B., Gezginci-Oktayoglu S., Arda-Pirincci P., Bolkent S. and Alpertunga B. (2009). Methiocarb-induced oxidative damage following subacute exposure and the protective effects of vitamin E and taurine in rats. Food Chem. Toxicol. 47, 1676-1684.
63. Parildar-Karpuzoglu H., Mehmetcik G., Ozdemirler-Erata G., Dogru-Abbasoglu S., Kocak-Toker N. and Uysal M. (2008). Effect of taurine treatment on pro-oxidant-antioxidant balance in livers and brains of old rats. Pharmacol. Rep. 60, 673-678.
64. Paueksakon P., Revelo M.P., Ma L.J., Marcantoni C. and Fogo A.B. (2002). Microangiopathic injury and augmented PAI-1 in human diabetic nephropathy. Kidney Int. 61, 2142-2148.
65. Phelps K.R., Naylor K., Brien T.P., Wilbur H. and Haqqie S.S. (1999). Encephalopathy after bladder irrigation with alum: case report and literature review. Am. J. Med. Sci. 318, 181-185.
66. Popinska K., Kierkus J., Lyszkowska M., Socha J., Pietraszek E., Kmiotek W. and Ksiazyk J. (1999). Aluminum contamination of parenteral nutrition additives, amino acid solutions, and lipid emulsions. Appl. Nutr. Invest. 15, 683-686.
67. Racusen L.C., Prozialeck D.H. and Solez K. (1984). Glomerular epithelial cell changes after ischemia or dehydration. Possible role of angiotensin II. Am. J. Pathol. 114, 157-163.
68. Roy A.K., Talukder G. and Sharma A. (1991). Similar effects in vivo of two aluminium salts on the liver, kidney, bone, and brain of Rattus norvegicus. Bull. Environ. Contam. Toxicol. 47, 288-295.
69. Sahin G., Varol I. and Temizer A. (1994). Determination of aluminium levels in the kidney, liver and brain of mice treated with aluminium hydroxide. Biol. Trace Elem. Res. 41, 129-135.
70. Sargazi M., Roberts N.B. and Shenkin A. (2001). In-vitro studies of aluminium-induced toxicity on kidney proximal tubular cells. J. Inorg. Biochem. 87, 37-43.
71. Sato S., Dai W., Liu X.L. and Asano G. (1999). The protective effect of hepatocyte growth-promoting factor (pHGF) against carbon tetrachloride-induced acute liver injury in rats: an ultrastructural study. Med. Electron Microsc. 32, 184-192.
72. Sato S., Yamate J., Saito T., Hosokawa T., Saito S. and Kurasaki M. (2002). Protective effect of taurine against renal interstitial fibrosis of rats induced by cisplatin. Naunyn Schmiedebergs Arch. Pharmacol. 365, 277-283.
73. Schrijvers B.F., Flyvbjerg A. and De Vriese A.S. (2003). The role of vascular endothelial growth factor (VEGF) in renal pathophysiology. Kidney Int. 65, 2003-2017.
74. Somova L.I., Missankov A. and Khan M.S. (1997). Chronic aluminium intoxication in rats: dose-dependent morphological changes. Methods Find. Exp. Clin. Pharmacol. 19, 599-604.
75. Sood P.K., Nahar U. and Nehru B. (2011). Curcumin attenuates aluminum-induced oxidative stress and mitochondrial dysfunction in rat brain. Neurotox. Res. 20, 351-361.
76. Tabassum H., Rehman H., Banerjee B.D., Raisuddin S. and Parvez S. (2006). Attenuation of tamoxifen-induced hepatotoxicity by taurine in mice. Clin. Chim. Acta 370, 129-136.
77. Tabassum H., Parvez S., Rehman H., Banerjee B.D., Siemen D. and Raisuddin S. (2007). Nephrotoxicity and its prevention by taurine in tamoxifen induced oxidative stress in mice. Hum. Exp. Toxicol. 26, 509-518.
78. Timbrell J.A., Seabra V. and Waterfield C.J. (1995). The in vivo and in vitro protective properties of taurine. Gen. Pharmacol. 26, 453-462.
79. Viezeliene D., Rodovicius H. and Ivanov L. (2006). Effect of aluminum ions on the activities of tRNALeu and leucyl-tRNA synthetase in mouse liver in vivo and in vitro. Biologija 4, 28-30.
80. Wang L., Yu Y., Zhang L., Wang Y., Niu N. and Guo L.M. (2008). Taurine rescues vascular endothelial dysfunction in streptozocininduced diabetic rats: correlated with downregulation of LOX-1 and ICAM-1 expression on aortas. Eur. J. Pharmacol. 597, 75-80.
81. Waters E., Wang J.H., Redmond H.P., Wu Q.D., Kay E. and Bouchier-Hayes D. (2001). Role of taurine in preventing acetaminopheninduced hepatic injury in the rat. Am. J. Physiol-Gastr. L. 280, 1274-1279.
82. Wilhelm M., Jaeger D.E., Schull-Cablitz H., Hafner H. and Idel H. (1996). Hepatic clearance and retention of aluminium: studies in the isolated per fused rat liver. Toxicol. Lett. 89, 257-263.
83. Wills M.R., Hewitt C.D., Sturgill B.C., Savory J., Herman M.M. (1993). Long term oral or intravenous aluminium administration in rabbits. I. Renal and hepatic changes. Ann. Clin. Lab. Sci. 23, 1-16.
84. Xie C.X. and Yokel R.A. (1996). Aluminum facilitation of iron mediated lipid per oxidation is dependent on substrate, pH and aluminum and iron concentrations. Arch. Biochem. Biophys. 327, 222-226.
85. Yeh Y.H., Lee Y.T., Hsieh H.S. and Hwang D.F. (2009). Effect of taurine on toxicity of aluminum in rats. Eur. J. Clin. Nutr. Metab. 4, e187-e192.
86. Yousef M.I. (2004). Aluminum-induced changes in hemato-biochemical parameters, lipid peroxidation and enzyme activities of male rabbits: Protective role of ascorbic acid. Toxicology 199, 47-57.
87. Yousef M.I., El-Morsy A.M.A. and Hassan M.E. (2005). Aluminiuminduced deterioration in reproductive performance and seminal plasma biochemistry of male rabbits: Protective role of ascorbic acid. Toxicology 215, 97-107.
88. Yousef M.I., Kamel I.K., El-Guendi I.E. and El-Demerdash F.M. (2007). An in vitro study on reproductive toxicity of aluminium chloride on rabbit sperm: The protective role of some antioxidants. Toxicology 239, 213-223.
89. Zatta P., Lain E. and Cagnolini C. (2000). Effect of aluminium on activity of Krebs cycle enzymes and glutamate dehydrogenase in rat brain homogenate. Eur. J. Biochem. 267, 3049-3055.
90. Zulli A. (2011). Taurine in cardiovascular disease. Curr. Opin. Clin. Nutr. Metab. Care 14, 57-60.